Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D and Improved Insulin Sensitivity

Research synthesisModerate evidenceMixed effect size9 studies · 6 beneficial · 3 neutral · 0 harmful

Across 9 studies, 6 reported beneficial effects of vitamin D supplementation on insulin sensitivity, with effect sizes ranging from small to moderate; the remaining 3 studies found neutral effects. The majority of beneficial findings come from meta-analyses and RCTs in clinical populations such as women with PCOS, gestational diabetes, or obesity, with effects more apparent in vitamin D-deficient individuals. Median study duration was 63 days, suggesting effects may take 8-12 weeks to observe.

  • Effective dose range: 1000-4000 IU/day
  • Studied populations: women with PCOS, women with gestational diabetes, patients with diabetes/prediabetes, obese/overweight children and adolescents, epilepsy patients, sarcopenic obesity

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Benefit appears strongest in vitamin D-deficient populations, and effects are often modest and inconsistent in replete individuals.

Generated Jun 14, 2026
Doses used in studies
  • IU/day: 1,000–4,000 (median 2,000, IQR 1,5003,000) 3 studies
Time to effect
Median: 9 weeks · IQR 7.5 weeks10.5 weeks · Range 6 weeks2.8 months — Reported in 2 of 9 studies
Safety in these studies
9 of 9 papers
Back to top